Citigroup

Citigroup’s Picard Medical PMI Stock Holding History

Citigroup’s Portfolio PMI Stock Details PMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5	Closed	-$263	–	6419
2026 Q1	$263	Hold	5	–	–	﹤0.01%	5564
2025 Q4	$448	Buy	+5	New	+$1.18K	﹤0.01%	5600

Other funds holding PMI

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Parcion Private Wealth Bellevue, Washington $1.8B AUM 30.57% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Citigroup's PMI Position: Q2 2026 in Review

Citigroup sold out of Picard Medical (PMI) in Q2 2026, closing a stake of 5 shares — an estimated $263 sold.

Citigroup first reported a position in PMI in Q4 2025 and held it in 2 quarters. The position peaked at $448 in Q4 2025. 13 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

Citigroup reported no remaining Picard Medical position as of Q2 2026 after selling out during the quarter.
Citigroup sold 5 Picard Medical shares in Q2 2026, an estimated $263.
Citigroup first reported a position in Picard Medical in Q4 2025 and held it in 2 quarters.
Citigroup's Picard Medical position peaked at $448 in Q4 2025.
13 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.